Moderna Expects Its Vaccine to Be Effective Against New Variants of Coronavirus

WASHINGTON (Sputnik) – US-based pharmaceutical firm Moderna expects that its COVID-19 vaccine is efficient in opposition to the brand new strains of the coronavirus that had been not too long ago found within the United Kingdom.

“Based on the data to date, Moderna expects that the vaccine-induced immunity from the Moderna COVID-19 Vaccine would be protective against the variants of the SARS-CoV-2 virus recently described in the UK. We will be performing additional tests of the vaccine in the coming weeks to confirm this expectation,” Moderna mentioned.

Last week, London introduced {that a} new coronavirus pressure had been detected within the nation, including that the brand new variant was up to 70 % extra transmissible than different SARS-CoV-2 variants. After the information emerged, many international locations suspended journey to and from the UK. However, there is no such thing as a proof that the brand new pressure is extra pathogenic.

On Wednesday, UK Health Secretary Matt Hancock mentioned {that a} second new variant of the SARS-CoV-2 allegedly originating from South Africa was discovered within the nation. On Thursday, the United Kingdom banned entry for passengers touring from South Africa.

Earlier this week, the builders of the Russian vaccine mentioned that Sputnik V could be efficient in opposition to any mutation of COVID-19, together with the brand new pressure, whereas the co-founder of BioNTech assured the agency’s vaccine is “highly likely” to work in opposition to the mutated pressure detected within the UK.


Related posts